Published in Chest on January 15, 2008
Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med (2011) 2.36
Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes (2009) 1.85
Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS One (2012) 1.02
Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study. Health Qual Life Outcomes (2014) 0.99
Assessment of Health-related Quality of Life among Patients with Tuberculosis in Hamadan, Western Iran. Oman Med J (2014) 0.95
A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life. Qual Life Res (2012) 0.89
Clinical symptoms and microbiological outcomes in tuberculosis treatment trials. Tuberculosis (Edinb) (2011) 0.84
Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis. PLoS One (2012) 0.82
The experience of college students with pulmonary tuberculosis in Shaanxi, China: a qualitative study. BMC Infect Dis (2010) 0.81
High social anxiety and poor quality of life in patients with pulmonary tuberculosis. Medicine (Baltimore) (2015) 0.78
Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa. Health Qual Life Outcomes (2016) 0.78
Health-related quality of life and tuberculosis: a longitudinal cohort study. Health Qual Life Outcomes (2015) 0.78
Evaluation of Health-Related Quality of Life among Tuberculosis Patients in Two Cities in Yemen. PLoS One (2016) 0.77
How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis - Designing a Prospective Observational Study in South Africa. Front Pharmacol (2016) 0.76
Change in Health-Related Quality of Life among Pulmonary Tuberculosis Patients at Primary Health Care Settings in South Africa: A Prospective Cohort Study. PLoS One (2016) 0.76
Health-Related Quality of Life, Depression and Anxiety in Hospitalized Patients with Tuberculosis. Tuberc Respir Dis (Seoul) (2016) 0.75
Effects of Multidrug Resistant Tuberculosis Treatment on Patients' Health Related Quality of Life: Results from a Follow Up Study. PLoS One (2016) 0.75
Health-related quality of life in South African patients with pulmonary tuberculosis. PLoS One (2017) 0.75
Knowledge and Attitudes About Tuberculosis Among U.S.-Born Blacks and Whites with Tuberculosis. J Immigr Minor Health (2015) 0.75
Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati. J Int Med Res (2017) 0.75
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One (2009) 4.92
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis (2004) 2.73
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest (2006) 2.37
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Empyema: an increasing concern in Canada. Can Respir J (2008) 2.26
Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med (2012) 2.21
Bronchial thermoplasty for asthma. Am J Respir Crit Care Med (2006) 2.15
The effect of universal influenza immunization on mortality and health care use. PLoS Med (2008) 2.01
The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care (2010) 1.95
Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ (2007) 1.91
Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes (2009) 1.85
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med (2010) 1.81
The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis (2009) 1.77
Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach. J Occup Environ Med (2005) 1.70
Antibiotic use in children is associated with increased risk of asthma. Pediatrics (2009) 1.68
Nurse staffing levels and hospital mortality in critical care settings: literature review and meta-analysis. J Adv Nurs (2006) 1.60
Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population. Pharmacogenomics (2009) 1.55
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J (2005) 1.52
Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest (2009) 1.47
Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ (2007) 1.43
The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada. Can Respir J (2005) 1.38
Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes (2004) 1.35
Health state utilities in latent and active tuberculosis. Value Health (2008) 1.34
The cost effectiveness of human papillomavirus vaccines: a systematic review. Drugs (2012) 1.30
Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000. BMC Health Serv Res (2005) 1.27
A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. MedGenMed (2007) 1.18
Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada. Can J Infect Dis (2004) 1.17
Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ (2002) 1.12
Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs (2007) 1.11
Evaluation of the Do Bugs Need Drugs? program in British Columbia: Can we curb antibiotic prescribing? Can J Infect Dis Med Microbiol (2011) 1.04
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest (2010) 1.04
Direct health care costs associated with asthma in British Columbia. Can Respir J (2010) 1.03
Screening immigrants for latent tuberculosis: do we have the resources? CMAJ (2014) 0.98
Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med (2013) 0.96
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96
Variations in the management of acute exacerbations of chronic obstructive pulmonary disease. Can Respir J (2013) 0.96
After patients are diagnosed with knee osteoarthritis, what do they do? Arthritis Care Res (Hoboken) (2010) 0.96
Current recommendations for the treatment of mild asthma. J Asthma Allergy (2010) 0.95
Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sex Transm Infect (2010) 0.94
Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital. BMC Health Serv Res (2006) 0.93
A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy. J Clin Epidemiol (2009) 0.93
Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting beta-agonist use in asthma. Chest (2004) 0.93
Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care Res (Hoboken) (2012) 0.92
Patients with genital warts have a decreased quality of life. Sex Transm Dis (2009) 0.92
Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials. J Clin Epidemiol (2008) 0.91
A systematic review of intradermal influenza vaccines. Vaccine (2011) 0.91
A systematic review of economic evaluations of therapy in asthma. J Asthma Allergy (2010) 0.90
Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada. Vaccine (2006) 0.89
Pharmacists' preferences for providing patient-centered services: a discrete choice experiment to guide health policy. Ann Pharmacother (2010) 0.87
A valuation of patients' willingness-to-pay for insulin delivery in diabetes. Int J Technol Assess Health Care (2009) 0.87
Economic and humanistic burden of external genital warts. Pharmacoeconomics (2012) 0.86
Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis. Mol Diagn Ther (2015) 0.86
Trends in antibiotic utilization in Vancouver associated with a community education program on antibiotic use. Can J Public Health (2010) 0.86
Cost-effectiveness of LTBI treatment for TB contacts in British Columbia. Value Health (2008) 0.85
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. J Pharm Sci (2004) 0.85
Health literacy, language, and ethnicity-related factors in newcomer asthma patients to Canada: a qualitative study. J Immigr Minor Health (2011) 0.85
Peripheral blood gene expression changes during allergen inhalation challenge in atopic asthmatic individuals. J Asthma (2012) 0.85
Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity? J Infect Dis (2008) 0.84
Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum (2007) 0.84
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome. Value Health (2009) 0.83
Individual- and regional-level determinants of human papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study. BMC Public Health (2014) 0.82
A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants. Mol Diagn Ther (2015) 0.81
Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest (2005) 0.81
Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: a cross-sectional study. BMC Pulm Med (2012) 0.81
Epidemiology of invasive pneumococcal disease in BC during the introduction of conjugated pneumococcal vaccine. Can J Public Health (2008) 0.80
Complementary and alternative asthma treatments and their association with asthma control: a population-based study. BMJ Open (2013) 0.80
Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes. Diabetes Technol Ther (2009) 0.80
A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection. Appl Health Econ Health Policy (2015) 0.79
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 0.79
An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment. J Asthma (2008) 0.79
Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge. Proteomics Clin Appl (2012) 0.79
Primary immune deficiencies presenting in adults: seven years of experience from Iran. J Clin Immunol (2005) 0.79
The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI). BMJ Open (2014) 0.78
Does antibiotic exposure during infancy lead to development of asthma? A systematic review and metaanalysis. 2006. Chest (2009) 0.78
Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment. Value Health (2011) 0.78
What counts as cultural competency in telehealth interventions? A call for new directions. J Telemed Telecare (2012) 0.78
Responses to comments of Weis. Health Qual Life Outcomes (2010) 0.78
Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis (2010) 0.78
Antibiotic prescribing by dentists has increased: Why? J Am Dent Assoc (2016) 0.78
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 0.77
Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. Ann Pharmacother (2002) 0.76
Review of evidence for measuring drug concentrations of first-line antitubercular agents in adults. Clin Pharmacokinet (2014) 0.76
The prevalence and predictors of tuberculin positivity in subjects screened for reasons other than contact investigation. Can Respir J (2008) 0.76
Post-hospital syndrome in adults with asthma: a case-crossover study. Allergy Asthma Clin Immunol (2013) 0.75
Evaluation of booking systems for elective surgery using simulation experiments. Healthc Policy (2008) 0.75
A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value Health (2013) 0.75